Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

ACP Cardi and Respi system > ACP L20 Pathology of lung and pleural tumors > Flashcards

ACP L20 Pathology of lung and pleural tumors Flashcards

1
Q

Give examples of local clinical features of lung cancer. (5)

A
  • Cough
  • Hemoptysis
  • Obstructive pneumonia
  • Compression effect: SVCO, Pancoast tumor
  • Pleural effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Patient with severe shoulder pain radiating to axilla and scapula, atrophy of hand and arm muscles.
Ptosis, miosis, and enophthalmos spotted.
CXR showed edema.
DDx?

A

Pancoast tumor

  • affects brachial plexus, cervical sympathetic nerves, Horner’s syndrome
  • Compression of blood vessels with edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lung cancers cause systemic presentations such as constitutional symptoms (weight loss, LOA, cachexia, LG fever).
List paraneoplastic syndromes that are more common in SQCC, SCLC. (3)

A
  1. Neurological
    - common in SCLC, e.g. Lambert-Eaton myasthenic syndrome (proximal muscle weakness)
  2. Endocrine
    - Cushing’s syndrome, SIADH, hypercalcemia of malignancy
    - in SQCC but not in SCLC
    - oncogenic osteomalacia
  3. Rheumatological
    - hypertrophic osteoarthropathy
    - dermatomyositis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common metastases of lung cancer? (2)

A
  1. To bone - pathological fracture

2. To brain - seizures, neurological manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do we classify lung cancers?

A
  1. Primary
    a) Small cell lung carcinoma (SCLC)

b) Non-small cell carcinoma (NSCLC)
- squamous cell carcinoma
- adenocarcinoma
- large cell carcinoma
- adenosquamous carcinoma

  1. Secondary
    - Metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which lung cancer has the weakest association with smoking and happens most frequently in young female non-smokers?

  • It is also the MC primary lung Ca
A

Adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Comment on the glandular differentiation (gross + microscopic) of adenocarcinoma of the lung. (2)

Also state histochemical findings and immunohistochemical findings. (2)

A

Glandular differentiation
- gross: acinar (forming gland), with multiple patterns in a single tumor

  • microscopic: mucin content

Histochemical: mucin stain
IHC: lung markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A 75 years-old smoker, complained of productive cough, on-and-off fever and weight loss for 4 months.
PE revealed diminished inspiration and crepitation of his right chest. CXR suggested collapsed right middle lobe and haziness at the right central region.

What is the most likely histologic type of lung CA and why? (2)

A

(Primary) Squamous cell carcinoma.

  • Elderly male smoker
  • Malignancy match with cachexia and weight loss
  • Location matches with the clinical picture
    1. central/peri-hilar lesion
    2. obstruction to distal bronchi
    3. collapse/obstructive pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the usual location for adenocarcinoma of the lungs?

A

From peripheral to central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

For squamous cell carcinoma of the lungs, comment on the squamous differentiation (gross + microscopic) (2).
Also comment on the IHC findings of the course of developement. (3)

A

Squamous differentiation:

  1. Gross: keratinization
  2. Microscopic: intracellular bridges

IHC
- Squamous metaplasia > dysplasia > carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Small cell lung carcinoma of the lungs is strongly associated with smoking and is usually _________located.

What are the histological features of SCLC?

A

Centrally;

  1. “Small cell = oat cell”: moulding of nuclei + scanty cytoplasm
  2. Hyperchromatic nuclei
  3. Fine chromatin
  4. Inconspicuous (not prominent) nucleoli
  5. Frequent mitotic figures and apoptotic bodies
  6. Azzopardi effect: hematoxyphilic vascular walls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chromogranin and synaptophysin are NE (neuroendocrine) markers that would be IHC +ve in __________ tumors? What prognosis?

A

Small cell lung carcinoma

- Poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

For Adenocarcinoma in situ, there can be single/multiple lesions <3cm, without any invasion.

What can be seen on CXR and what is its prognosis?

A

CXR:
- Ground glass appearance: spread along the wall without invading airway

Excellent prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Minimally invasive adenocarcinoma is a single lesion <3cm with <5 mm of stromal invasion (lepidic pattern) without lymphatic vessels, blood vessels or __________ invasion.

What can be seen on CXR? Prognosis?

A

pleural invasion

  • Ground glass appearance with central opacity

Excellent prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is large cell lung carcinoma diagnosed?

A

Diagnosed by exclusion: NSCLC lacking morphologic differentiation of adenocarcinoma/ SQCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Carcinoid tumor of the lung accounts for 10% of all carcinoid tumor and is only 1% of all lung tumors.

It can be classified into typical (benign) and atypical (may be malignant).

What histological features? (2)

A
  1. Organoid pattern

2. Neuroendocrine features (+ve for NE markers, neuro-secretory granules)

17
Q

The lung is a common site for metastasis.

List possible primary sites in order. (3)

A

Breast > Colon > RCC

18
Q

For metastasis to the lungs, which 2 types of spread is possible and how do they differ in the presentation? (4)

A
  1. Hematogenous spread
    - multiple cannon ball lesions
    - distributed diffusely in the lung parenchyma
  2. Lymphatic spread (lymphangitis carcinomatosis)
    - peripheral (interlobular septum, pleural surface)
    - central (bronchoalveolar interstitium)
19
Q

What is a synchronous tumor and a metachronous tumor? (2)

How to differentiate them from others. (2)

A

Synchronous tumor: multiple primary tumors

Metachronous tumor: new primary tumor after surgery

Synchronous VS intra-pulmonary metastasis
Metachronous tumor VS metastasis after surgery

  • differentiated by both pathological + radiological evidence
20
Q

Pleural mesothelioma risk factor?

  1. Extensive pleural fibrosis
  2. Plaque
  3. Mesothelioma
A

Exposure to asbestos, with delayed presentation (25-40 latent years)

21
Q

Clinical presentations in patients with pleural mesothelioma? (3)

A
  1. Pleural effusion
  2. Symptoms due to compression, i.e. SVCO, Pancoast tumor
  3. Relentless local spread, but metastasis rare
22
Q

A 75 years-old smoker, complained of productive cough, on-and-off fever and weight loss for 4 months.
PE revealed diminished inspiration and crepitation of his right chest. CXR suggested collapsed right middle lobe and haziness at the right central region.

(b) How would you investigate and what are your reasons? (2)

A
  1. Blood tests: Neutrophilia and leucocytosis
  2. Sputum for cytology: malignancy
  3. Sputum for culture and sensitivity: infection and Abx needed
  4. Bronchoscopy with biopsy: central/perihilar lesion
  5. CT thorax: SOL in right chest
23
Q

A 75 years-old smoker, complained of productive cough, on-and-off fever and weight loss for 4 months.
PE revealed diminished inspiration and crepitation of his right chest. CXR suggested collapsed right middle lobe and haziness at the right central region.

(a)DDx?

A
  1. Lung tumor
  2. Bronchiectasis
  3. Atelectasis
  4. COPD
  5. Chest infection
24
Q

What are the molecular classifications of adenocarcinoma? (3)

A

EGFR > KRAS > ALK as driver mutations

KRAS > EGFR in western countries

25
Q

EGFR mutation?
Constitutive activation of EGFR downstream signaling pathway independent of EGF, causing cell proliferation, migration, invasion and inhibition of apoptosis.

What is the significance of knowing whether the patient has EGFR mutation?

A

EGFR mutation enables the use of EGFR TKI (tyrosine kinase inhibitors) such as gefitinib, erlotinib

  • responsive! in lung ADC
26
Q

Other than lung ADC, EGFR overexpression is seen in 80% of Colorectal ADC.
What targeted therapy to be given (1) and what molecular tests have to be done before that? (1) Why? (1)

A

Anti-EGFR monoclonal Antibody
e.g. cetuximab, panitumumab

Molecular test
- if KRAS/NRAS mutation +ve > no response to the above treatment

27
Q

Treatment for KRAS mutation and ALK mutation?

A

KRAS mutation - no drug

ALK inhibitors: crizotinib

28
Q

Treatment for EGFR mutation in lung ADC? (name the drugs)

A

EGFR TKI: Gefitinib, erlotinib

29
Q

What is PD-1? How is it related to treatment of lung tumor?

A
  • Tumor cells express PD-L1 (programme death ligand_ in attempt to suppress T cell response
  • Check PD-L1 expression on tumor cells
  • Immunotherapy: PD-1 receptor agonist: pembrolizumab
30
Q

How is ALK mutation be tested?

A

FISH - testing ALK translocation

31
Q

(e) What are the treatments of choice for early-stage and advance-stage primary lung CA? (2)

A

Early-stage: surgical intervention +/- chemotherapy/radiotherapy

Advanced stage: Targeted therapy

ACP Cardi and Respi system (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions